Mr. William J. Hartig, PreScript Pharmaceuticals; The law requires the Petitioner to state with particularity the Petitioner’s set of circumstances and to specify the statutory provision, rule, or order that the Petitioner believes may apply to the ...

 

DEPARTMENT OF BUSINESS AND PROFESSIONAL REGULATION

Drugs, Devices and Cosmetics

NOTICE IS HEREBY GIVEN that Department of Business and Professional Regulation, Division of Drugs, Devices and Cosmetics has declined to rule on the petition for declaratory statement filed by Mr. William J. Hartig, PreScript Pharmaceuticals on April 13, 2016. The following is a summary of the agency’s declination of the petition:

The law requires the Petitioner to state with particularity the Petitioner’s set of circumstances and to specify the statutory provision, rule, or order that the Petitioner believes may apply to the set of circumstances. See, Section 120.565(2), Florida Statutes (2015), infra. Petitioner has not done this. Specifically, the Petitioner failed to provide facts with regard to what the company does on a day to day basis; where the company receives the drugs that it repackages; where the company distributes the drugs; and the relationship, if any, between Prescript and the companies to whom it distributes the drugs. Based on the foregoing, the Department declines to issue a declaratory statement, and the Petition is DENIED.

A copy of the Order Declining of the Petition for Declaratory Statement may be obtained by contacting: The Division of Drugs, Devices and Cosmetics, 2601 Blair Stone Road, Tallahassee, FL 32399-1047 or calling [phone].

Please refer all comments to Reginald D. Dixon, Division Director, Division of Drugs, Devices and Cosmetics, 2601 Blair Stone Road, Tallahassee, FL 32399-1047 or call [phone].